AzTrials
AzTrials

Shoulder Arthropathy Associated With Other ConditionsREACHRSANCT06162858

Reaching Motion During Functional Activities

A study testing IMU (Inertial Measurement Devices) in people with Shoulder Arthropathy Associated With Other Conditions and Healthy, run by University Hospital, Ghent at 2 sites in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Taking and moving objects is essential. When this becomes difficult, it affects daily functioning. This study aims to determine movement patterns, at the level of the shoulder, during different functional movements in elderly people aged 60 years and older. Read more about this study

Who is it for?
Ages 60 years and olderHealthy volunteers can take part
What is being tested?
IMU (Inertial Measurement Devices)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
2 sitesBelgium
Study dates
15 Oct 2023to 30 Sep 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • 60 years and older
  • no shoulder pain + no diagnosis of shoulder problem
  • primary reverse shoulder arthroplasty

Who cannot join

  • younger than 60 years
  • shoulder pain at moment of testing
  • known shoulder problem ( incl. diagnosis)

Trial locations and contacts

2 sites in 1 country.

Dominiek Vandenbosch, MSc contact

+32 9 332 16 69

dominiek.vandenbosch@ugent.be

Alexander Van Tongel, PhD contact

alexander.vantongel@uzgent.be

Belgium2 sites, 2 recruiting
  • Ghent University Hospital

    Ghent, 9000

    Dominiek Vandenbosch, Msc, +32476439601, dominiek.vandenbosch@ugent.be

    Alexander Van Tongel, PhD, alexander.vantongel@uzgent.be

    Recruiting
  • University Ghent

    Ghent, 9000

    Dominiek Vandenbosch, MSc, +32 9 332 16 69, dominiek.vandenbosch@ugent.be

    Annelies Maenhout, Phd, annelies.maenhout@ugent.be

    Recruiting

Other trials in Belgium

About this study

Official title: Reaching Motion by the Elderly During Functional Activities. A Comparison Beween a Healthy Control Group and Patients With a Reverse Shoulder Arthroplasty

Taking and moving objects is essential. When this becomes difficult, it affects daily functioning. This study aims to determine movement patterns, at the level of the shoulder, during different functional movements in elderly people aged 60 years and older. Movement patterns of people without shoulder problems and patients with a reverse shoulder prosthesis will be compared. These insights can contribute to improving functional rehabilitation in patients with a reverse shoulder prosthesis (RSA).

Read the detailed description

This study aims to investigate how elderly people (60 years and older) without shoulder pain and patients with a reverse shoulder arthroplasty (60 years and older) perform functional reaching movements. Using IMUs (Inertial Measurement Units), the investigators want to look at mode of execution, relational positions of hand, elbow and shoulder in space, in relation to the trunk and each other, and any compensatory movements made by patients with a reverse shoulder arthroplasty.

At the time of testing, participants will first complete a series of questionnaires. These questionnaires will provide information about the daily functioning of all participants. The participants' shoulder strength will also be measured.

After applying the IMUs, the participant will first perform a maximal movement (active for participant) in 4 directions (forward and lateral lifting of arm, hand-to-neck , hand-to-back). Then the researcher will perform the same movements with the participant's arm (passive for participant). This will allow measurement of the maximum active and passive mobility of the shoulder. Next, the participant will be asked to place and take back a number of different objects (both in terms of size and weight) at predetermined heights.

The participants without shoulder pain will be tested once, the participants with a reverse shoulder arthroplasty we want to test 4 times. The participants without shoulder pain will be assigned to the control group. The participants with a reverse shoulder arthroplasty we want to test 4 times to monitor not only their movement pattern, but also any changes in this pattern .

The questionnaires, strength measurement and requested movements will be the same for both groups.

Analysis of these movements will provide us with insights that can help improve the functional rehabilitation of patients with a reverse shoulder prosthesis.

All participants with a reverse shoulder arthroplasty will be recruited at UZ, participants without shoulder pain will be recruited through different channels (these are not patients)

Being tested
IMU (Inertial Measurement Devices)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • IMU (Inertial Measurement Devices)Other

    Functional placing and reaching of objects of different weights on different heights

Study groups in NCT06162858
Study groupRoleWhat they receive
Healthy participantsOtherno shoulder pain no shoulder diagnosis 60 years and older
Receives: Other: IMU (Inertial Measurement Devices)
RSA participantsOtherprimary reverse shoulder arthroplasty 60 years and older
Receives: Other: IMU (Inertial Measurement Devices)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: healthy control group: baseline

  2. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: RSA group: 3 weeks post surgery

  3. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: RSA group: 6 weeks post surgery

  4. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: RSA group: 12 weeks post surgery

  5. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: RSA group: 6 months post surgery

  6. IMU registration (3D kinematics upper limb)

    kinematic registration of performed exercises by all participants

    Measured: RSA group: 12 months post surgery

Secondary outcomes (7)
  1. SPADI_DV

    Content: 5 questions for the subscale pain and 8 questions for the disability subscale.

    Scoring: numeric rating scale from 1 to 10, with a maximum of 130. The total score is the sum of the sub-scores.

    Interpretation: The higher the score the more pain and disability. The lower the score, the better patients perceive their shoulder

    Measured: during procedure

  2. Constant- Murley Score

    Content: partially clinical (65 points) and partially PROM (35 points) assessed.

    Scoring: The formula to calculate the total score is:" pain (0-15) + ADL (4x (0-5) = 0-20) + mobility (4 x (0-10) = 0-40)

    + strength (0 -25)". Strength will be measured with the arm elevated to 90 ° in the scapular plane using an IDOmeter.

    Interpretation: 0-55 points = bad, 56-70 points = mediocre, 71-85 points = good, 86-100 points = excellent score

    Measured: during procedure

  3. EQ5D5L

    Content: 5 questions + EQ-5D VAS for general health. Scoring: 5-response scale (from 'no problems' to 'extreme problems') + VAS percentage between 0 (worst imaginable health state) and 100 (best imaginable health state).

    Interpretation: VAS score for general health indicates how a patient perceives his general health, Other questions are descriptive for problems in mobility, self-care, usual activities, pain/ discomfort, anxiety/depression

    Measured: during procedure

  4. VAS-pain

    Pain is scored between 0 and 10. 0 = no pain, 10= worst possible pain

    Measured: during procedure

  5. AROM

    active range of motion for forward flexion, abduction, hand-to-neck, hand-to-back forward flexion and abduction with extended elbow, functional internal and external rotation in standing position.

    • maximal pain free ROM
    • forward flexion and abduction with extended elbow: measured with the EasyAngle (Meloq AB Sweden)
    • hand-to-back and hand-to-neck test : scored as in Constant-Murley Score

    Measured: during procedure

  6. PROM

    passive range of motion for forward flexion and abduction

    • maximal pain free ROM
    • measured with the EasyAngle (Meloq AB Sweden)

    Measured: during procedure

  7. strength

    strength will be measured for forward flexion in 0° elevation and in 90° elevation with the EasyForce.

    FF at 0° elevation: participants will sit on a chair without backrest, both feet on the ground. Arm in neutral rotation, hand in a fist, thumb facing upward FF at 90° elevation: participants will stand, the arm with extended elbow held at 90° elevation (FF). Hand in a fist, thumb facing upward

    Measured: during procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2023
  2. Study start15 Oct 2023
  3. Primary completion30 Sep 2026 (estimated)
  4. Study completion30 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06162858
Sponsor's protocol ID
ONZ-2023-0416
Acronym
REACHRSA
Status last verified
Nov 2023
First submitted
6 Nov 2023
Last updated
8 Dec 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing IMU (Inertial Measurement Devices) in people with Shoulder Arthropathy Associated With Other Conditions and Healthy, run by University Hospital, Ghent at 2 sites in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Dec 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Dominiek Vandenbosch, MSc (+32 9 332 16 69, dominiek.vandenbosch@ugent.be), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

IMU registration (3D kinematics upper limb) (time frame: healthy control group: baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in